Pila Pharma Danmark ApS: Financial statements 2022
CVR: 39023636
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Pila Pharma Danmark ApS (CVR 39023636) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -13,423,297 and a net result of DKK -10,823,402 compared with DKK -5,052,324 the year before. Equity in the 2022 report amounted to DKK 2,978,940. The solvency ratio was 72%.
- Gross Profit
- DKK -13,423,297
- Profit/Loss
- DKK -10,823,402
- Equity
- DKK 2,978,940
- Total Assets
- DKK 4,138,806
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -13.4M | -10.8M | 3M | - |
| 2021 | - | -6.4M | -5.1M | 1.3M | - |
| 2020 | - | -3.5M | -2.8M | 854K | 0 |
| 2019 | - | -2.4M | -2.1M | 909K | 1 |
Official annual report
Keep an eye on Pila Pharma Danmark ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Pila Pharma Danmark ApS has published its annual report for 2021. Gross profit came to DKK -6,366,086, and the net result was DKK -5,052,324.
About Pila Pharma Danmark ApS
Pila Pharma Danmark ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2017. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Dorte Xenia Gram. The company is owned by Pila Pharma AB. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -4,798,283 and a net result of DKK -3,780,896 compared with DKK -3,094,589 the year before. Equity in the 2025 report amounted to DKK 2,596,207.